23andMe files for bankruptcy after data breach and financial struggles
BBC - 24-Mar-2025Company is looking for a buyer, raising concerns about the security of customer DNA data
Investments News
Bit.bio cuts 25% of staff as it shifts from therapy development to lab research
FierceBiotech - 19-Mar-2025Company aims to grow its product line and biotech partnerships
Mito Health raised $4 million to grow its AI-powered health platform
Longevity Technology - 18-Mar-2025It uses blood tests to find early health risks and gives personalised advice
AstraZeneca bets $1 billion on revolutionary cancer therapy
The Guardian - 17-Mar-2025AstraZeneca acquires EsoBiotec to revolutionize cell therapy with faster, more accessible treatments
Augustine Therapeutics raises $84.8m for safer neuro and metabolic drugs
Longevity Technology - 12-Mar-2025Clinical trials are beginning, backed by major investors like Novo Holdings
Hinge Health is filing for an IPO after cutting losses and boosting revenue
Endpoints News - 10-Mar-2025The IPO could mark a revival in digital health investments
Scientists plan to reproduce groundbreaking rejuvenation experiment in rats
Live Forever Club - 06-Mar-2025No donation too small to help extend Katcher's extracellular particles study
Trimtech secures $31m to tackle neurodegenerative diseases
Longevity Technology - 06-Mar-2025Targeted protein degradation tackles harmful aggregates while sparing healthy proteins
Tenaya raises $52.5m to push forward gene therapy trials
Longevity Technology - 05-Mar-2025The biotech firm accelerates clinical trials for TN-201 and TN-401, targeting genetic heart disease
AbbVie joins the obesity drug race with $2.2b Gubra deal
Endpoints News - 03-Mar-2025The pharma giant bets on amylin therapy to enter the weight-loss market
Biograph: the elite longevity startup redefining preventive health
TechCrunch - 28-Feb-2025Backed by Peter Attia, this startup uses advanced diagnostics to optimize lifespan
Vertex ends gene editing deal with Verve amid R&D shift
FierceBiotech - 27-Feb-2025Verve regains full rights to its liver disease program as it moves forward independently
Cyclarity Therapeutics advances series A tranche 2 funding to accelerate breakthrough cardiovascular treatment
Live Forever Club - 20-Feb-2025Statins only slow down the progression of atherosclerosis – imagine if we could actually cure it!
Maxwell Biosciences makes progress in infectious disease treatment
Live Forever Club - 19-Feb-2025Investors are taking interest as the company moves toward human trials
Subsense unveils non-surgical brain-computer interface with $17m boost
MassDevice - 18-Feb-2025Nanoparticles power a new era of brain-computer interaction
Europe’s first 100m consumer health fund targets proactive care revolution
Longevity Technology - 18-Feb-2025naturalX backs startups reshaping wellness and prevention
Mair Therapeutics targets Parkinson’s with AI-driven drug discovery
Longevity Technology - 17-Feb-2025The Dutch startup is using ion channel research and advanced tech to develop new treatments
VERIGRAFT secures 1.2m to revolutionize 3D-printed arterial grafts
Tech.eu - 14-Feb-2025A Eurostars-backed project advancing personalized vascular grafts
Junevity secures $10m to pioneer “cell reset” therapies for longevity
Longevity Technology - 13-Feb-2025Backed by AI and genetics, Junevity targets age-related diseases
Five Alarm Bio seeking funding to develop drugs targeting the chronic diseases of ageing
Live Forever Club - 12-Feb-2025Promising preclinical results suggest a clear path towards drug development
Nucleus brings whole-genome health testing to the masses
Longevity Technology - 30-Jan-2025Cutting-edge DNA analysis provides affordable, real-time health insights
The NAM catalyst award: Inspiring bold ideas for a healthier future in ageing
Live Forever Club - 27-Jan-2025Winners receive $50,000 and global networking opportunities
Neko Health secures $260m to revolutionize preventive care
Longevity Technology - 23-Jan-2025Full-body scans drive early detection as Neko expands globally
LinkGevity’s drug fights ageing and kidney disease, gains NASA’s support
Business Weekly - 23-Jan-2025With backing from NASA and the Crick Institute, clinical trials are set to begin
Convergence Medical raises $3.1m for groundbreaking surgical robot
MassDevice - 21-Jan-2025V01, the first arthroscopic robot, gains FDA breakthrough status and targets global growth
Display all news
